Biosafety and Health (Jun 2019)
Intra-host Ebola viral adaption during human infection
- William J. Liu,
- Weifeng Shi,
- Wuyang Zhu,
- Cong Jin,
- Shumei Zou,
- Ji Wang,
- Yuehua Ke,
- Xiaofeng Li,
- Mi Liu,
- Tao Hu,
- Hang Fan,
- Yigang Tong,
- Xiang Zhao,
- Wenbin Chen,
- Yuhui Zhao,
- Di Liu,
- Gary Wong,
- Chengchao Chen,
- Chunyu Geng,
- Weiwei Xie,
- Hui Jiang,
- Idrissa Laybor Kamara,
- Abdul Kamara,
- Matt Lebby,
- Brima Kargbo,
- Xiangguo Qiu,
- Yu Wang,
- Xiaofeng Liang,
- Mifang Liang,
- Xiaoping Dong,
- Guizhen Wu,
- George F. Gao,
- Yuelong Shu
Affiliations
- William J. Liu
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Weifeng Shi
- Shandong Universities Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases, Taishan Medical University, Taian 271000, China
- Wuyang Zhu
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Cong Jin
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Shumei Zou
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Ji Wang
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Yuehua Ke
- Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing 100071, China
- Xiaofeng Li
- State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
- Mi Liu
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Tao Hu
- Shandong Universities Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases, Taishan Medical University, Taian 271000, China
- Hang Fan
- State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
- Yigang Tong
- State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
- Xiang Zhao
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Wenbin Chen
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Yuhui Zhao
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
- Di Liu
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
- Gary Wong
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
- Chengchao Chen
- BGI-Shenzhen, Shenzhen 518083, China
- Chunyu Geng
- BGI-Shenzhen, Shenzhen 518083, China
- Weiwei Xie
- BGI-Shenzhen, Shenzhen 518083, China
- Hui Jiang
- BGI-Shenzhen, Shenzhen 518083, China
- Idrissa Laybor Kamara
- Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone
- Abdul Kamara
- Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone
- Matt Lebby
- Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone
- Brima Kargbo
- Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone
- Xiangguo Qiu
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
- Yu Wang
- Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Xiaofeng Liang
- Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Mifang Liang
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Xiaoping Dong
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- Guizhen Wu
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
- George F. Gao
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; Chinese Center for Disease Control and Prevention, Beijing 102206, China; Corresponding authors: National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
- Yuelong Shu
- NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Public Health School (Shenzhen), Sun Yat-sen University, Shenzhen 510006, China; Corresponding authors: National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
- Journal volume & issue
-
Vol. 1,
no. 1
pp. 14 – 24
Abstract
The onsite next generation sequencing (NGS) of Ebola virus (EBOV) genomes during the 2013–2016 Ebola epidemic in Western Africa provides an opportunity to trace the origin, transmission, and evolution of this virus. Herein, we have diagnosed a cohort of EBOV patients in Sierra Leone in 2015, during the late phase of the outbreak. The surviving EBOV patients had a recovery process characterized by decreasing viremia, fever, and biochemical parameters. EBOV genomes sequenced through the longitudinal blood samples of these patients showed dynamic intra-host substitutions of the virus during acute infection, including the previously described short stretches of 13 serial T>C mutations. Remarkably, within individual patients, samples collected during the early phase of infection possessed Ts at these nucleotide sites, whereas they were replaced by Cs in samples collected in the later phase, suggesting that these short stretches of T>C mutations could emerge independently. In addition, up to a total of 35 nucleotide sites spanning the EBOV genome were mutated coincidently. Our study showed the dynamic intra-host adaptation of EBOV during patient recovery and gave more insight into the complex EBOV-host interactions.